Yield10 Bioscience, Inc.
YTENQ
$0.015
$0.000.00%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 750.00K | 300.00K | 60.00K | 147.00K | 258.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 750.00K | 300.00K | 60.00K | 147.00K | 258.00K |
| Cost of Revenue | 7.06M | 7.39M | 8.19M | 8.12M | 7.99M |
| Gross Profit | -6.31M | -7.09M | -8.13M | -7.97M | -7.74M |
| SG&A Expenses | 6.16M | 5.83M | 6.15M | 6.27M | 6.29M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.34M | 13.36M | 14.48M | 14.52M | 14.42M |
| Operating Income | -12.59M | -13.06M | -14.42M | -14.37M | -14.16M |
| Income Before Tax | -12.70M | -13.15M | -14.46M | -14.36M | -14.12M |
| Income Tax Expenses | -- | -- | -- | 129.00K | 138.00K |
| Earnings from Continuing Operations | -12.70 | -13.15 | -14.46 | -14.49 | -14.26 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.70M | -13.15M | -14.46M | -14.49M | -14.26M |
| EBIT | -12.59M | -13.06M | -14.42M | -14.37M | -14.16M |
| EBITDA | -12.32M | -12.77M | -14.13M | -14.09M | -13.88M |
| EPS Basic | -26.30 | -36.68 | -50.07 | -59.56 | -66.61 |
| Normalized Basic EPS | -16.44 | -22.92 | -31.29 | -36.83 | -41.21 |
| EPS Diluted | -26.30 | -36.68 | -50.07 | -59.56 | -66.62 |
| Normalized Diluted EPS | -16.44 | -22.92 | -31.29 | -36.83 | -41.21 |
| Average Basic Shares Outstanding | 2.03M | 1.63M | 1.32M | 1.03M | 858.20K |
| Average Diluted Shares Outstanding | 2.03M | 1.63M | 1.32M | 1.03M | 858.20K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
